Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037.
Jack H. Skirball Center for Chemical Biology and Proteomics, The Salk Institute for Biological Studies, La Jolla, CA 92037.
Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2563-E2570. doi: 10.1073/pnas.1621513114. Epub 2017 Mar 20.
The peroxisome proliferator-activated receptor (PPAR) family comprises three subtypes: PPARα, PPARγ, and PPARδ. PPARδ transcriptionally modulates lipid metabolism and the control of energy homeostasis; therefore, PPARδ agonists are promising agents for treating a variety of metabolic disorders. In the present study, we develop a panel of rationally designed PPARδ agonists. The modular motif affords efficient syntheses using building blocks optimized for interactions with subtype-specific residues in the PPARδ ligand-binding domain (LBD). A combination of atomic-resolution protein X-ray crystallographic structures, ligand-dependent LBD stabilization assays, and cell-based transactivation measurements delineate structure-activity relationships (SARs) for PPARδ-selective targeting and structural modulation. We identify key ligand-induced conformational transitions of a conserved tryptophan side chain in the LBD that trigger reorganization of the H2'-H3 surface segment of PPARδ. The subtype-specific conservation of H2'-H3 sequences suggests that this architectural remodeling constitutes a previously unrecognized conformational switch accompanying ligand-dependent PPARδ transcriptional regulation.
过氧化物酶体增殖物激活受体 (PPAR) 家族包括三种亚型:PPARα、PPARγ 和 PPARδ。PPARδ 转录调节脂质代谢和能量稳态的控制;因此,PPARδ 激动剂是治疗多种代谢紊乱的有前途的药物。在本研究中,我们开发了一组合理设计的 PPARδ 激动剂。模块化基序可使用针对 PPARδ 配体结合域 (LBD) 中特定于亚型的残基相互作用进行优化的构建块进行高效合成。原子分辨率的蛋白质 X 射线晶体结构、配体依赖性 LBD 稳定测定和基于细胞的转激活测量相结合,描绘了 PPARδ 选择性靶向和结构调节的构效关系 (SAR)。我们确定了 LBD 中保守色氨酸侧链的关键配体诱导构象转变,该转变触发 PPARδ 的 H2'-H3 表面片段的重组。H2'-H3 序列的亚型特异性保守性表明,这种结构重塑构成了伴随配体依赖性 PPARδ 转录调节的以前未被识别的构象开关。